Recent

% | $
Quotes you view appear here for quick access.

Geron Corporation (GERN) Message Board

  • scistats scistats Dec 10, 2013 1:31 PM Flag

    Safety, efficacy, and dose management complete. Phase 2 partner now needed.

    Safety, efficacy, and dose management have been defined.

    Geron now needs a partner, along with cash.

    If and when a partnership is announced, this will be the next catalyst.
    Expect the partnership agreement to involve some up-front cash with the vast majority of the reward on the back end.

    Until a partnership happens, those looking for quick cash will not stick around, so GERN will drop a bit as expected.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Go it alone !

      Vette

      Sentiment: Strong Buy

    • Very sensible post. Something along the lines of an HGSI Glaxo Smith Klein deal regarding Benlysta. A 50/50 development and cost /profit share structure. With a large cash upfront deal. Very likely scenario in my book. Might not be today or tomorrow, but after a larger clinical trial progresses. Will all depend on future results in trial. Nothing more. Nothing less.

      • 1 Reply to wehaveignition
      • I think the Mayo results are substantial enough to justify an agreement in the near future, with most of the cash of any such agreement coming on the backside. Geron may have to give a little more than they would like to get this done, but I believe they will do this sooner rather than later. The only other option is a buyout, and they do not have the data to support this option for what it might be worth.

        Sentiment: Strong Buy

 
GERN
4.15-0.25(-5.68%)Jul 2 4:00 PMEDT